TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,
A SBIR Phase II contract was awarded to TRANSPOSAGEN BIOPHARMACEUTICALS, INC. for $650,666.0 USD from the U.S. Department of Health & Human Services.
All edits
Edits on 27 Jun, 2023
Golden AI
Infobox
Government Agency
0
Award Amount (USD)
650,6660
SBIR/STTR Award Recipient
Contract Number (US Government)
2R44RR021289-02A10
Award Phase
Phase II0
Award Type
SBIR0
Edits on 11 May, 2021
Golden AI
Edits made to:
Infobox (+1/-1 properties)
Infobox
Edits on 13 Mar, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,
Infobox
Is a
Award Type
SBIR
Award Identifier
2R44RR021289-02A1
Phase
Phase II
Amount (USD)
650,666
Find more entities like TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
